Shots:
- The CHMP has recommended Boey (trenibotulinumtoxinE) to improve the appearance of mod. to sev. glabellar lines in adults temporarily; decision is expected in the coming mos., & would apply across all 30 EEA states
- Opinion was supported by data from 2 P-III trials assessing the efficacy & safety of Boey in adults with mod. to sev. glabellar lines (M21-500 & M21-508)
- The trials met all their 1 & 2EPs, showing rapid onset of action as early as 8hrs. after administration (the earliest assessment time) & observed efficacy duration for 2-3wks.
Ref: AbbVie | Image: Allergan Aesthetics | Press Release
Related News: Genmab and AbbVie Report the US FDA Approval of Epkinly to Treat R/R Follicular Lymphoma
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
